-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Neutral on Merck & Co, Raises Price Target to $155

Benzinga·11/02/2026 12:32:02
Diffusion vocale
Cantor Fitzgerald analyst Carter Gould maintains Merck & Co (NYSE:MRK) with a Neutral and raises the price target from $145 to $155.